American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

KAZIA THERAPEUTICS LTD (KZIA)

$16.90 +15.75% NASDAQ: KZIA · 15-min delayed

NEW SOUTH WALES 2113, C3
Public · NASDAQ: KZIA
6 employees

Visit website Follow

$140.1MMarket cap

6Employees

KZIANASDAQ

1999IPO

About KAZIA THERAPEUTICS LTD

Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NASDAQ: KZIA
Employees: 6
IPO date: Jan 6, 1999
Headquarters: 140 WICKS RD
NEW SOUTH WALES 2113, C3 2113
Phone: 01161298780088
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: KZIA Nasdaq
SEC CIK: 1075880
SIC: 2834 PHARMACEUTICAL PREPARATIONS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Kazia Therapeutics Ltd’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/kazia-therapeutics-ltd/"><img src="https://americancompanies.com/badge/kazia-therapeutics-ltd.svg" alt="Kazia Therapeutics Ltd — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow KAZIA THERAPEUTICS LTD and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Market cap: $140.1M

NASDAQ: KZIA

$16.90 +15.75%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$5.00 $16.90

52-week range

Market cap: $140.1M
Shares outstanding: 8.3M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Jan 6, 1999

Kazia Therapeutics Ltd (KZIA) Stock Price

Trading near its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review KAZIA THERAPEUTICS LTD.

Write a review

Newsroom

News about KAZIA THERAPEUTICS LTD

Glioblastoma Clinical Trial Landscape Expands: Over 200 Companies Advancing Next-Generation Therapies | DelveInsight GlobeNewswire Inc. · 2026-06-16 · positive Kazia Therapeutics Appoints James Levine as Chief Financial Officer Benzinga · 2026-06-02 · positive Glioblastoma Multiforme Market Poised for Significant Growth at a CAGR of 13.2% During the Forecast Period (2026–2036), as Next-Generation Therapies Enter Late-Stage Development | DelveInsight GlobeNewswire Inc. · 2026-05-27 · positive Kazia Therapeutics Expands Oncology Platform with First-in-Class SETDB1 Inhibitor Drug Development Platform Benzinga · 2026-04-13 · positive Kazia Therapeutics to Participate in J.P. Morgan Healthcare Conference Week; Clinical and Translational Update Anticipated Before Month-End Benzinga · 2026-01-08 · positive Kazia Therapeutics Achieves Initial iCR (Immune-Complete Response) in Metastatic TNBC and Delivers Q4 Business Update with Breakthroughs Across Breast Cancer, Immuno-Oncology, and GBM Regulatory Strategy Benzinga · 2025-11-18 · positive

News & sentiment via Polygon.io

FAQ

Kazia Therapeutics Ltd: frequently asked questions

Is Kazia Therapeutics Ltd an American company?

Kazia Therapeutics Ltd is a US-based company headquartered in New South Wales 2113, C3, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Kazia Therapeutics Ltd headquartered?

Kazia Therapeutics Ltd is headquartered in New South Wales 2113, C3, United States.

Is Kazia Therapeutics Ltd publicly traded?

Yes — Kazia Therapeutics Ltd is a publicly traded company. Its stock trades under the ticker symbol KZIA on the NASDAQ.

What does Kazia Therapeutics Ltd do?

Kazia Therapeutics Ltd is an American Pharmaceuticals company in the Health & Beauty sector.

Explore